PGVinvest AB invests in Diamyd Medical
Diamyd Medical today announced that the investment company PGVinvest AB has acquired 953,333 series B unit rights and 46,667 series B shares in Diamyd Medical from Anders Essen-Möller, major owner of Diamyd Medical. All unit rights and shares were taken from an endowment insurance, meaning that the holding specified for Essen-Möller in the published prospectus remains unchanged. Anders Essen-Möller has announced that the entire sales proceeds will be used as part of Essen-Möller’s forthcoming investment in Diamyd Medical’s impending rights issue. About Diamyd MedicalDiamyd Medical